Optimizing Number of Potency Assays Performed to Accelerate Commercialization without Draining Resources

Time: 4:30 pm
day: Day 1


  • Balancing the quantity of potency assays performed with their relative time and resource strain
  • Prioritizing assay development based on scientific rationale and regulatory expectations (including absolute potency assays, employing signal enhancers, and utilizing orthogonal methods)
  • How to invest in relevant assays upfront to optimize resource use and mitigate financial risk
  • To what extent can we streamline assay selection to accelerate commercialization?